Table of Content

1 Biothrax (Anthrax Vaccine) Market Overview
1.1 Product Overview and Scope of Biothrax (Anthrax Vaccine)
1.2 Biothrax (Anthrax Vaccine) Segment by Type
1.2.1 Global Biothrax (Anthrax Vaccine) Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Live Vaccines
1.2.3 Cell Free PA Vaccines
1.3 Biothrax (Anthrax Vaccine) Segment by Application
1.3.1 Biothrax (Anthrax Vaccine) Sales Comparison by Application: (2021-2027)
1.3.2 Human Use
1.3.3 Animal Use
1.4 Global Biothrax (Anthrax Vaccine) Market Size Estimates and Forecasts
1.4.1 Global Biothrax (Anthrax Vaccine) Revenue 2016-2027
1.4.2 Global Biothrax (Anthrax Vaccine) Sales 2016-2027
1.4.3 Biothrax (Anthrax Vaccine) Market Size by Region: 2016 Versus 2021 Versus 2027

2 Biothrax (Anthrax Vaccine) Market Competition by Manufacturers
2.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Manufacturers (2016-2021)
2.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Biothrax (Anthrax Vaccine) Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Biothrax (Anthrax Vaccine) Manufacturing Sites, Area Served, Product Type
2.5 Biothrax (Anthrax Vaccine) Market Competitive Situation and Trends
2.5.1 Biothrax (Anthrax Vaccine) Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Biothrax (Anthrax Vaccine) Players Market Share by Revenue
2.5.3 Global Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Biothrax (Anthrax Vaccine) Retrospective Market Scenario by Region
3.1 Global Biothrax (Anthrax Vaccine) Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Biothrax (Anthrax Vaccine) Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.3.1 North America Biothrax (Anthrax Vaccine) Sales by Country
3.3.2 North America Biothrax (Anthrax Vaccine) Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.4.1 Europe Biothrax (Anthrax Vaccine) Sales by Country
3.4.2 Europe Biothrax (Anthrax Vaccine) Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Biothrax (Anthrax Vaccine) Market Facts & Figures by Region
3.5.1 Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region
3.5.2 Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.6.1 Latin America Biothrax (Anthrax Vaccine) Sales by Country
3.6.2 Latin America Biothrax (Anthrax Vaccine) Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Biothrax (Anthrax Vaccine) Market Facts & Figures by Country
3.7.1 Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country
3.7.2 Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Biothrax (Anthrax Vaccine) Historic Market Analysis by Type
4.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2021)
4.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Type (2016-2021)
4.3 Global Biothrax (Anthrax Vaccine) Price by Type (2016-2021)

5 Global Biothrax (Anthrax Vaccine) Historic Market Analysis by Application
5.1 Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2021)
5.2 Global Biothrax (Anthrax Vaccine) Revenue Market Share by Application (2016-2021)
5.3 Global Biothrax (Anthrax Vaccine) Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Merial
6.1.1 Merial Corporation Information
6.1.2 Merial Description and Business Overview
6.1.3 Merial Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Merial Product Portfolio
6.1.5 Merial Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Merck Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Zoetis
6.3.1 Zoetis Corporation Information
6.3.2 Zoetis Description and Business Overview
6.3.3 Zoetis Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Zoetis Product Portfolio
6.3.5 Zoetis Recent Developments/Updates
6.4 Bayer Sanidad Animal
6.4.1 Bayer Sanidad Animal Corporation Information
6.4.2 Bayer Sanidad Animal Description and Business Overview
6.4.3 Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Bayer Sanidad Animal Product Portfolio
6.4.5 Bayer Sanidad Animal Recent Developments/Updates
6.5 Colorado Serum
6.5.1 Colorado Serum Corporation Information
6.5.2 Colorado Serum Description and Business Overview
6.5.3 Colorado Serum Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Colorado Serum Product Portfolio
6.5.5 Colorado Serum Recent Developments/Updates
6.6 PharmAthene
6.6.1 PharmAthene Corporation Information
6.6.2 PharmAthene Description and Business Overview
6.6.3 PharmAthene Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.6.4 PharmAthene Product Portfolio
6.6.5 PharmAthene Recent Developments/Updates
6.7 Tiankang
6.6.1 Tiankang Corporation Information
6.6.2 Tiankang Description and Business Overview
6.6.3 Tiankang Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Tiankang Product Portfolio
6.7.5 Tiankang Recent Developments/Updates
6.8 Biogénesis-Bago
6.8.1 Biogénesis-Bago Corporation Information
6.8.2 Biogénesis-Bago Description and Business Overview
6.8.3 Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Biogénesis-Bago Product Portfolio
6.8.5 Biogénesis-Bago Recent Developments/Updates
6.9 CAVAC
6.9.1 CAVAC Corporation Information
6.9.2 CAVAC Description and Business Overview
6.9.3 CAVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.9.4 CAVAC Product Portfolio
6.9.5 CAVAC Recent Developments/Updates
6.10 Rosenbusch
6.10.1 Rosenbusch Corporation Information
6.10.2 Rosenbusch Description and Business Overview
6.10.3 Rosenbusch Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Rosenbusch Product Portfolio
6.10.5 Rosenbusch Recent Developments/Updates
6.11 Agrovet
6.11.1 Agrovet Corporation Information
6.11.2 Agrovet Biothrax (Anthrax Vaccine) Description and Business Overview
6.11.3 Agrovet Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Agrovet Product Portfolio
6.11.5 Agrovet Recent Developments/Updates
6.12 Vecol
6.12.1 Vecol Corporation Information
6.12.2 Vecol Biothrax (Anthrax Vaccine) Description and Business Overview
6.12.3 Vecol Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Vecol Product Portfolio
6.12.5 Vecol Recent Developments/Updates
6.13 CVCRI
6.13.1 CVCRI Corporation Information
6.13.2 CVCRI Biothrax (Anthrax Vaccine) Description and Business Overview
6.13.3 CVCRI Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.13.4 CVCRI Product Portfolio
6.13.5 CVCRI Recent Developments/Updates
6.14 IVPM
6.14.1 IVPM Corporation Information
6.14.2 IVPM Biothrax (Anthrax Vaccine) Description and Business Overview
6.14.3 IVPM Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.14.4 IVPM Product Portfolio
6.14.5 IVPM Recent Developments/Updates
6.15 Prondil
6.15.1 Prondil Corporation Information
6.15.2 Prondil Biothrax (Anthrax Vaccine) Description and Business Overview
6.15.3 Prondil Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.15.4 Prondil Product Portfolio
6.15.5 Prondil Recent Developments/Updates
6.16 CDV
6.16.1 CDV Corporation Information
6.16.2 CDV Biothrax (Anthrax Vaccine) Description and Business Overview
6.16.3 CDV Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.16.4 CDV Product Portfolio
6.16.5 CDV Recent Developments/Updates
6.17 Indian Immunologicals
6.17.1 Indian Immunologicals Corporation Information
6.17.2 Indian Immunologicals Biothrax (Anthrax Vaccine) Description and Business Overview
6.17.3 Indian Immunologicals Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.17.4 Indian Immunologicals Product Portfolio
6.17.5 Indian Immunologicals Recent Developments/Updates
6.18 Botswana Vaccine Institute
6.18.1 Botswana Vaccine Institute Corporation Information
6.18.2 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Description and Business Overview
6.18.3 Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.18.4 Botswana Vaccine Institute Product Portfolio
6.18.5 Botswana Vaccine Institute Recent Developments/Updates
6.19 Ceva Santé Animale
6.19.1 Ceva Santé Animale Corporation Information
6.19.2 Ceva Santé Animale Biothrax (Anthrax Vaccine) Description and Business Overview
6.19.3 Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.19.4 Ceva Santé Animale Product Portfolio
6.19.5 Ceva Santé Animale Recent Developments/Updates
6.20 Intervac
6.20.1 Intervac Corporation Information
6.20.2 Intervac Biothrax (Anthrax Vaccine) Description and Business Overview
6.20.3 Intervac Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.20.4 Intervac Product Portfolio
6.20.5 Intervac Recent Developments/Updates
6.21 JOVAC
6.21.1 JOVAC Corporation Information
6.21.2 JOVAC Biothrax (Anthrax Vaccine) Description and Business Overview
6.21.3 JOVAC Biothrax (Anthrax Vaccine) Sales, Revenue and Gross Margin (2016-2021)
6.21.4 JOVAC Product Portfolio
6.21.5 JOVAC Recent Developments/Updates

7 Biothrax (Anthrax Vaccine) Manufacturing Cost Analysis
7.1 Biothrax (Anthrax Vaccine) Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
7.4 Biothrax (Anthrax Vaccine) Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Biothrax (Anthrax Vaccine) Distributors List
8.3 Biothrax (Anthrax Vaccine) Customers

9 Biothrax (Anthrax Vaccine) Market Dynamics
9.1 Biothrax (Anthrax Vaccine) Industry Trends
9.2 Biothrax (Anthrax Vaccine) Growth Drivers
9.3 Biothrax (Anthrax Vaccine) Market Challenges
9.4 Biothrax (Anthrax Vaccine) Market Restraints

10 Global Market Forecast
10.1 Biothrax (Anthrax Vaccine) Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Biothrax (Anthrax Vaccine) by Type (2022-2027)
10.2 Biothrax (Anthrax Vaccine) Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Biothrax (Anthrax Vaccine) by Application (2022-2027)
10.3 Biothrax (Anthrax Vaccine) Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Biothrax (Anthrax Vaccine) by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Biothrax (Anthrax Vaccine) by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Biothrax (Anthrax Vaccine) Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Biothrax (Anthrax Vaccine) Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Biothrax (Anthrax Vaccine) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Biothrax (Anthrax Vaccine) Covered in This Study
Table 5. Global Biothrax (Anthrax Vaccine) Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Biothrax (Anthrax Vaccine) Sales Share by Manufacturers (2016-2021)
Table 7. Global Biothrax (Anthrax Vaccine) Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Biothrax (Anthrax Vaccine) Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Biothrax (Anthrax Vaccine) Manufacturing Sites and Area Served
Table 11. Manufacturers Biothrax (Anthrax Vaccine) Product Type
Table 12. Global Biothrax (Anthrax Vaccine) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Biothrax (Anthrax Vaccine) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biothrax (Anthrax Vaccine) as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Biothrax (Anthrax Vaccine) Sales by Region (2016-2021) & (K Units)
Table 16. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2016-2021)
Table 17. Global Biothrax (Anthrax Vaccine) Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Biothrax (Anthrax Vaccine) Sales by Country (2016-2021) & (K Units)
Table 19. North America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2016-2021)
Table 20. North America Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2016-2021)
Table 22. Europe Biothrax (Anthrax Vaccine) Sales by Country (2016-2021) & (K Units)
Table 23. Europe Biothrax (Anthrax Vaccine) Sales Market Share by Country (2016-2021)
Table 24. Europe Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Biothrax (Anthrax Vaccine) Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Biothrax (Anthrax Vaccine) Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Biothrax (Anthrax Vaccine) Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2016-2021)
Table 30. Latin America Biothrax (Anthrax Vaccine) Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Biothrax (Anthrax Vaccine) Sales Market Share by Country (2016-2021)
Table 32. Latin America Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Biothrax (Anthrax Vaccine) Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Biothrax (Anthrax Vaccine) Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Biothrax (Anthrax Vaccine) Revenue Market Share by Country (2016-2021)
Table 38. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Type (2016-2021)
Table 39. Global Biothrax (Anthrax Vaccine) Sales Market Share by Type (2016-2021)
Table 40. Global Biothrax (Anthrax Vaccine) Revenue (Million US$) by Type (2016-2021)
Table 41. Global Biothrax (Anthrax Vaccine) Revenue Share by Type (2016-2021)
Table 42. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Type (2016-2021)
Table 43. Global Biothrax (Anthrax Vaccine) Sales (K Units) by Application (2016-2021)
Table 44. Global Biothrax (Anthrax Vaccine) Sales Market Share by Application (2016-2021)
Table 45. Global Biothrax (Anthrax Vaccine) Revenue (Million US$) by Application (2016-2021)
Table 46. Global Biothrax (Anthrax Vaccine) Revenue Share by Application (2016-2021)
Table 47. Global Biothrax (Anthrax Vaccine) Price (US$/Unit) by Application (2016-2021)
Table 48. Merial Corporation Information
Table 49. Merial Description and Business Overview
Table 50. Merial Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Merial Biothrax (Anthrax Vaccine) Product
Table 52. Merial Recent Developments/Updates
Table 53. Merck Corporation Information
Table 54. Merck Description and Business Overview
Table 55. Merck Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Merck Biothrax (Anthrax Vaccine) Product
Table 57. Merck Recent Developments/Updates
Table 58. Zoetis Corporation Information
Table 59. Zoetis Description and Business Overview
Table 60. Zoetis Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Zoetis Biothrax (Anthrax Vaccine) Product
Table 62. Zoetis Recent Developments/Updates
Table 63. Bayer Sanidad Animal Corporation Information
Table 64. Bayer Sanidad Animal Description and Business Overview
Table 65. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Bayer Sanidad Animal Biothrax (Anthrax Vaccine) Product
Table 67. Bayer Sanidad Animal Recent Developments/Updates
Table 68. Colorado Serum Corporation Information
Table 69. Colorado Serum Description and Business Overview
Table 70. Colorado Serum Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Colorado Serum Biothrax (Anthrax Vaccine) Product
Table 72. Colorado Serum Recent Developments/Updates
Table 73. PharmAthene Corporation Information
Table 74. PharmAthene Description and Business Overview
Table 75. PharmAthene Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. PharmAthene Biothrax (Anthrax Vaccine) Product
Table 77. PharmAthene Recent Developments/Updates
Table 78. Tiankang Corporation Information
Table 79. Tiankang Description and Business Overview
Table 80. Tiankang Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Tiankang Biothrax (Anthrax Vaccine) Product
Table 82. Tiankang Recent Developments/Updates
Table 83. Biogénesis-Bago Corporation Information
Table 84. Biogénesis-Bago Description and Business Overview
Table 85. Biogénesis-Bago Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Biogénesis-Bago Biothrax (Anthrax Vaccine) Product
Table 87. Biogénesis-Bago Recent Developments/Updates
Table 88. CAVAC Corporation Information
Table 89. CAVAC Description and Business Overview
Table 90. CAVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. CAVAC Biothrax (Anthrax Vaccine) Product
Table 92. CAVAC Recent Developments/Updates
Table 93. Rosenbusch Corporation Information
Table 94. Rosenbusch Description and Business Overview
Table 95. Rosenbusch Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. Rosenbusch Biothrax (Anthrax Vaccine) Product
Table 97. Rosenbusch Recent Developments/Updates
Table 98. Agrovet Corporation Information
Table 99. Agrovet Description and Business Overview
Table 100. Agrovet Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Agrovet Biothrax (Anthrax Vaccine) Product
Table 102. Agrovet Recent Developments/Updates
Table 103. Vecol Corporation Information
Table 104. Vecol Description and Business Overview
Table 105. Vecol Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Vecol Biothrax (Anthrax Vaccine) Product
Table 107. Vecol Recent Developments/Updates
Table 108. CVCRI Corporation Information
Table 109. CVCRI Description and Business Overview
Table 110. CVCRI Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. CVCRI Biothrax (Anthrax Vaccine) Product
Table 112. CVCRI Recent Developments/Updates
Table 113. IVPM Corporation Information
Table 114. IVPM Description and Business Overview
Table 115. IVPM Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. IVPM Biothrax (Anthrax Vaccine) Product
Table 117. IVPM Recent Developments/Updates
Table 118. Prondil Corporation Information
Table 119. Prondil Description and Business Overview
Table 120. Prondil Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Prondil Biothrax (Anthrax Vaccine) Product
Table 122. Prondil Recent Developments/Updates
Table 123. CDV Corporation Information
Table 124. CDV Description and Business Overview
Table 125. CDV Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. CDV Biothrax (Anthrax Vaccine) Product
Table 127. CDV Recent Developments/Updates
Table 128. Indian Immunologicals Corporation Information
Table 129. Indian Immunologicals Description and Business Overview
Table 130. Indian Immunologicals Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Indian Immunologicals Biothrax (Anthrax Vaccine) Product
Table 132. Indian Immunologicals Recent Developments/Updates
Table 133. Botswana Vaccine Institute Corporation Information
Table 134. Botswana Vaccine Institute Description and Business Overview
Table 135. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Botswana Vaccine Institute Biothrax (Anthrax Vaccine) Product
Table 137. Botswana Vaccine Institute Recent Developments/Updates
Table 138. Ceva Santé Animale Corporation Information
Table 139. Ceva Santé Animale Description and Business Overview
Table 140. Ceva Santé Animale Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Ceva Santé Animale Biothrax (Anthrax Vaccine) Product
Table 142. Ceva Santé Animale Recent Developments/Updates
Table 143. Intervac Corporation Information
Table 144. Intervac Description and Business Overview
Table 145. Intervac Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Intervac Biothrax (Anthrax Vaccine) Product
Table 147. Intervac Recent Developments/Updates
Table 148. JOVAC Corporation Information
Table 149. JOVAC Description and Business Overview
Table 150. JOVAC Biothrax (Anthrax Vaccine) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 151. JOVAC Biothrax (Anthrax Vaccine) Product
Table 152. JOVAC Recent Developments/Updates
Table 153. Production Base and Market Concentration Rate of Raw Material
Table 154. Key Suppliers of Raw Materials
Table 155. Biothrax (Anthrax Vaccine) Distributors List
Table 156. Biothrax (Anthrax Vaccine) Customers List
Table 157. Biothrax (Anthrax Vaccine) Market Trends
Table 158. Biothrax (Anthrax Vaccine) Growth Drivers
Table 159. Biothrax (Anthrax Vaccine) Market Restraints
Table 160. Global Biothrax (Anthrax Vaccine) Sales Forecast by Type (2022-2027) & (K Units)
Table 161. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Type (2022-2027)
Table 162. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 163. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Type (2022-2027)
Table 164. Global Biothrax (Anthrax Vaccine) Sales Forecast by Application (2022-2027) & (K Units)
Table 165. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Application (2022-2027)
Table 166. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 167. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Application (2022-2027)
Table 168. Global Biothrax (Anthrax Vaccine) Sales Forecast by Region (2022-2027) & (K Units)
Table 169. Global Biothrax (Anthrax Vaccine) Sales Market Share Forecast by Region (2022-2027)
Table 170. Global Biothrax (Anthrax Vaccine) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 171. Global Biothrax (Anthrax Vaccine) Revenue Market Share Forecast by Region (2022-2027)
Table 172. Research Programs/Design for This Report
Table 173. Key Data Information from Secondary Sources
Table 174. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Biothrax (Anthrax Vaccine)
Figure 2. Global Biothrax (Anthrax Vaccine) Market Share by Type in 2020 & 2027
Figure 3. Live Vaccines Product Picture
Figure 4. Cell Free PA Vaccines Product Picture
Figure 5. Global Biothrax (Anthrax Vaccine) Market Share by Application in 2020 & 2027
Figure 6. Human Use
Figure 7. Animal Use
Figure 8. Global Biothrax (Anthrax Vaccine) Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Biothrax (Anthrax Vaccine) Market Size 2016-2027 (US$ Million)
Figure 10. Global Biothrax (Anthrax Vaccine) Sales 2016-2027 (K Units)
Figure 11. Global Biothrax (Anthrax Vaccine) Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Biothrax (Anthrax Vaccine) Sales Share by Manufacturers in 2020
Figure 13. Global Biothrax (Anthrax Vaccine) Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Biothrax (Anthrax Vaccine) Players: Market Share by Revenue in 2020
Figure 15. Biothrax (Anthrax Vaccine) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region (2016-2021)
Figure 17. Global Biothrax (Anthrax Vaccine) Sales Market Share by Region in 2020
Figure 18. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region (2016-2021)
Figure 19. Global Biothrax (Anthrax Vaccine) Revenue Market Share by Region in 2020
Figure 20. U.S. Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Biothrax (Anthrax Vaccine) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Biothrax (Anthrax Vaccine) by Type (2016-2021)
Figure 45. Sales Market Share of Biothrax (Anthrax Vaccine) by Application (2016-2021)
Figure 46. Sales Market Share of Biothrax (Anthrax Vaccine) by Application in 2020
Figure 47. Revenue Share of Biothrax (Anthrax Vaccine) by Application (2016-2021)
Figure 48. Revenue Share of Biothrax (Anthrax Vaccine) by Application in 2020
Figure 49. Manufacturing Cost Structure of Biothrax (Anthrax Vaccine)
Figure 50. Manufacturing Process Analysis of Biothrax (Anthrax Vaccine)
Figure 51. Biothrax (Anthrax Vaccine) Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed